1[1]Cullinan SA,Moertel CG,Wieand HS,O'Connell MJ,Poon MA,Krook JE,Mailliard JA,Tschetter LK.Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer.North Central Cancer Treatment Group.J Clin Oncol 1994;12:412-416 被引量：1
2[2]Kim NK,Park YS,Heo DS,Suh C,Kim SY,Park KC,Kang YK,Shin DB,Kim HT,Kim HJ.A phase Ⅲ randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil,doxorubicin,and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.Cancer 1993;71:3813-3818 被引量：1
3[3]Ohtsu A,Shimada Y,Shirao K,Boku N,Hyodo I,Saito H,Yamamichi N,Miyata Y,Ikeda N,Yamamoto S,Fukuda H,Yoshida S.Randomized phase Ⅲ trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable,advanced gastric cancer:The Japan Clinical Oncology Group Study (JCOG9205).J Clin Oncol 2003;21:54-59 被引量：1
4[4]Ohtsu A.Current status and future prospects of chemotherapy for metastatic gastric cancer:a review.Gastric Cancer 2005;8:95-102 被引量：1
5[5]Kunimoto T,Nitta K,Tanaka T,Uehara N,Baba H,Takeuchi M,Yokokura T,Sawada S,Miyasaka T,Mutai M.Antitumor activity of a new camptothecin derivative,SN-22,against various murine tumors.J Pharmacobiodyn 1987;10:148-151 被引量：1
6[6]Futatsuki K,Wakui A,Nakao I,Sakata Y,Kambe M,Shimada Y,Yoshino M,Taguchi T,Ogawa N.Late phase Ⅱ study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer.CPT-11 Gastrointestinal Cancer Study Group.Gan To Kagaku Ryoho 1994;21:1033-1038 被引量：1
7[7]Shirao K,Shimada Y,Kondo H,Saito D,Yamao T,Ono H,Yokoyama T,Fukuda H,Oka M,Watanabe Y,Ohtsu A,Boku N,Fujii T,Oda Y,Muro K,Yoshida S.Phase Ⅰ-Ⅱ study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer.J Clin Oncol 1997;15:921-927 被引量：1
8[8]Boku N,Ohtsu A,Shimada Y,Shirao K,Seki S,Saito H,Sakata Y,Hyodo Ⅰ.Phase Ⅱ study of a combination of irinotecan and cisplatin against metastatic gastric cancer.J Clin Oncol 1999;17:319-323 被引量：1
9[9]Ajani JA,Baker J,Pisters PW,Ho L,Mansfield PF,Feig BW,Charnsangavej C.CPT-11 plus cisplatin in patients with advanced,untreated gastric or gastroesophageal junction carcinoma:results of a phase Ⅱ study.Cancer 2002;94:641-646 被引量：1
10[10]Fujitani K,Tsujinaka T,Hirao M.Pharmacokinetic study of two infusion schedules of irinotecan combined with cisplatin in patients with advanced gastric cancer.Oncology 2003;64:111-115 被引量：1
